Neurodegenerative Disease

CHARLOTTESVILLE, Va. and CARMEL, Ind., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Scientists at Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) have developed a synthetic model to potentially…

New York, United States, May 27, 2022 (GLOBE NEWSWIRE) -- Neurodegenerative diseases are a large and diverse group of disorders characterized by progressive deterioration of the function…

CHARLOTTESVILLE, Va. and CARMEL, Ind., March 16, 2022 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical stage biopharmaceutical company focused on the…

Incidence and mortality rates of amyotrophic lateral sclerosis (ALS) among the athletes who played in the National Football League (NFL) have been identified by a study published in the…

"We know that people are living longer and the general population is getting older, but that doesn't fully explain the increase we saw in the death rate in people with Parkinson's,"…

This offers new hope to tens of millions of sufferers of neurodegenerative diseases and the start-up also has the study entered in its Phase 1 clinical trials. …

It constitutes 60% of dementia, with 5-7% of the prevalence rate in European and North American population. In addition, the disease costs £26 billion a year to the UK economy. …

as per the World Health Organisation (WHO). Globally, the disease affects approximately 24 million people and the number is expected to double every 20 years. ‘Onset of Alzheimer’s disease…

The exact role of these proteins is limited. ‘Plaque build-up in Alzheimer’s disease and various neurodegenerative diseases can be prevented by restoring a “chaperone” protein called DAXX…

Due to BBB, achieving the delivery of this ASO therapy with systemic dosing and adequate concentrations in the central nervous system (CNS) has been difficult. ‘Specific group of drugs –…